TCM-based extracts reduce pain in oral lichen planus by 0.86 points on VAS
TCM Biological Extracts May Reduce Pain in Oral Lichen Planus
A meta-analysis of 22 articles found that traditional Chinese Medicine-based biological extracts significantly reduce visual analog scale sc…
New research suggests that traditional Chinese medicine based biological extracts may help reduce pain for people living with oral lichen pl…
NSP antibody detection aids DIVA interpretation in foot-and-mouth disease but has key limits
New ways to tell if livestock are vaccinated against disease
This mini review examines non-structural protein (NSP) antibody detection for DIVA serology in foot-and-mouth disease. It finds that NSP ser…
Identifying whether an animal was vaccinated or infected by a virus is tricky, but new protein markers may help clarify the history of infec…
Brain-Lung-Immune-Microbiome Axis replaces biomechanical models in understanding ventilator-associated pneumonia after traumatic brain injury
New Framework Explains Lung Infections After Brain Injuries
This narrative review explores the transition from a traditional biomechanical model of ventilator-associated pneumonia to a multidimensiona…
A new model suggests that brain injuries create a complex immune and microbiome response that leads to lung infections in intensive care pat…
FDA Approves Zithromax (azithromycin) for Mild to Moderate Bacterial Infections
FDA approves Zithromax to treat bacterial infections in adults and children.
The FDA approved Zithromax (azithromycin) for mild to moderate infections caused by susceptible bacteria, including acute bacterial exacerba…
The FDA approved Zithromax (azithromycin) for mild to moderate bacterial infections like bronchitis, sinusitis, pneumonia, and ear infection…
FDA Approves Zithromax (azithromycin) for Mild to Moderate Bacterial Infections
FDA approves new antibiotic Zithromax for bacterial infections
The FDA approved Zithromax (azithromycin) for mild to moderate infections caused by susceptible bacteria, including acute bacterial exacerba…
The FDA approved Zithromax (azithromycin) to treat mild to moderate bacterial infections like bronchitis, sinusitis, pneumonia, and skin inf…
FDA Approves Zithromax (azithromycin) for Multiple Bacterial Infections
FDA approves Zithromax to treat bacterial infections in adults and children.
The FDA approved Zithromax (azithromycin) for mild to moderate infections including acute bacterial exacerbations of chronic bronchitis, sin…
The FDA approved Zithromax (azithromycin) for mild to moderate bacterial infections like bronchitis, sinusitis, pneumonia, and skin infectio…
FDA Approves Zithromax (azithromycin) for Community-Acquired Pneumonia and Pelvic Inflammatory Disease
FDA approves new injectable antibiotic Zithromax for two serious infections.
The FDA approved Zithromax (azithromycin) for injection for community-acquired pneumonia and pelvic inflammatory disease in adults requiring…
The FDA approved Zithromax (azithromycin) for injection to treat community-acquired pneumonia and pelvic inflammatory disease in adults who …
FDA Approves Sporanox (itraconazole) for Blastomycosis, Histoplasmosis, Aspergillosis, and Onychomycosis
FDA approves Sporanox capsules for serious fungal infections and nail fungus.
FDA approved itraconazole capsules for blastomycosis, histoplasmosis, aspergillosis (in patients intolerant/refractory to amphotericin B), a…
The FDA approved Sporanox (itraconazole) capsules to treat fungal infections like blastomycosis, histoplasmosis, and aspergillosis in certai…
5-day oral antibiotics as effective as 10-day course for pediatric GAS pharyngitis
Shorter antibiotic courses may treat strep throat in children
A systematic review and dose-response meta-analysis of 22,636 children found little to no difference in clinical outcomes between 3, 5, and …
A review of over 20,000 cases suggests a 5-day course of antibiotics is as effective as 10 days for treating strep throat in children.
FDA Approves Fetroja (cefiderocol) for Complicated UTIs and Hospital-Acquired Pneumonia
FDA approves new antibiotic Fetroja for serious bacterial infections
The FDA approved Fetroja (cefiderocol) for complicated urinary tract infections (cUTI) including pyelonephritis, and hospital-acquired bacte…
The FDA approved Fetroja (cefiderocol) to treat complicated urinary tract infections and certain pneumonia types in adults. It targets hard-…
Vonoprazan-amoxicillin dual therapy is a safe alternative to bismuth-containing quadruple therapy for H. pylori
New vonoprazan treatments show promise for clearing H. pylori infection
This multicenter randomized controlled trial of 579 H. pylori-positive patients found that vonoprazan-amoxicillin (VA) dual therapy demonstr…
Two new simplified drug combinations could offer a simpler way to clear H. pylori infections, especially for patients with certain allergies…
Cefdinir and cefprozil show superior eradication rates compared to penicillin V for Group A streptococcal pharyngitis
Certain antibiotics work better than others for strep throat
This network meta-analysis of 64 RCTs involving 23,287 participants evaluated 24 antibiotics for Group A streptococcal (GAS) pharyngitis. Th…
New data shows that while some antibiotics effectively clear strep throat, azithromycin performs poorly and carries more risks.